Earnings News
Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.
Medtronic Hovers Near 52-Week Low as Market Awaits Earnings
Medtronic shares closed at $76.15, near their 52-week low, as broader market weakness weighed ahead of the company's June 3 earnings report.
Hyliion Stock Surges 90% on Q1 Earnings, KARNO Progress
Hyliion shares surged nearly 90% this week after Q1 revenue of $2.8 million and progress on its KARNO power module. The stock closed at $4.67 on Friday.
UiPath shares gain 6% ahead of Q1 earnings report
UiPath shares surged 6.2% to $10.27 on Friday, outperforming a declining tech sector, as traders await the company's fiscal Q1 earnings on May 28.
Netflix Stock Holds Steady as Ad Tier Reaches 250M Users
Netflix shares ended the week at $87.02, nearly unchanged, as the company revealed its ad-supported service now has 250 million global monthly active viewers and plans to expand to 15 more countries by 2027.
Cisco Hits Record High on AI Demand, Job Cuts Loom
Cisco shares hit an all-time high after boosting its AI revenue outlook and delivering better-than-expected results, while announcing job cuts to fund the transition.
NextNRG Revenue Climbs 29% but Cash Warning Looms
NextNRG's Q1 revenue surged 29% to $21.1M, but a widening net loss and cash crunch raise doubts about its ability to continue operations without new funding.
HCW Biologics Surges 262% on Trimmune Deal and Profit, Nasdaq Risk Looms
HCW Biologics shares jumped 262% after a licensing deal with Beijing Trimmune Biotech fueled a Q1 profit. The company still faces Nasdaq delisting risks and will seek shareholder approval for a reverse stock split.
P3 Health Partners Soars 200% After First Profit, Lifts 2026 Forecast
P3 Health Partners shares surged over 200% to $13 after posting its first quarterly profit and raising its 2026 adjusted EBITDA outlook. Net income reached $3 million, reversing a $44.2 million loss a year earlier.
UBS Maintains Sell on Ambev Despite Record Brazil Beer Volumes
Ambev shares edged down 0.25% after UBS raised its price target but maintained a Sell rating, as record Brazil beer volumes and strong cash flow were offset by rising costs and competitive pressures.
Pfizer Ramps Up India Expansion, Faces Investor Skepticism
Pfizer is expanding into India with cancer, obesity, and vaccine investments, but investors remain cautious. Q1 revenue rose 5% to $14.5 billion, though generic competition looms.
Archer Aviation's $8M Stock Issuance Revives Cash Burn Worries
Archer Aviation files to issue $8M in stock to vendors and register 3.27M shares for resale, intensifying cash burn scrutiny after a $217.7M Q1 loss.